The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Precision Promise (PrP): An adaptive, multi-arm registration trial in metastatic pancreatic ductal adenocarcinoma (PDAC).
 
Vincent J. Picozzi
Stock and Other Ownership Interests - Amgen; Cigna; Johnson & Johnson; McKesson; Thermo Fisher Scientific
Consulting or Advisory Role - TriSalus Life Sciences
Research Funding - Abbvie; FibroGen; Ipsen; NGM Biopharmaceuticals; NovoCure; Tyme
 
Anne-Marie Duliege
Stock and Other Ownership Interests - Abbvie; Amgen; Exelixis; Gilead Sciences; Jazz Pharmaceuticals; Regeneron
Consulting or Advisory Role - Federation Bio
 
Eric Andrew Collisson
Stock and Other Ownership Interests - BloodQ; Clara Health; Guardant Health; HDT Bio; Hint Health; IHP Therapeutics; One Medical; Tatara Therapeutics; Valar Labs
Research Funding - AstraZeneca (Inst); Ferro Oncology/Bridge Bio (Inst); Loxo/Bayer (Inst); Merck KGaA (Inst)
Expert Testimony - NantBioScience
 
Anirban Maitra
Consulting or Advisory Role - Freenome; Tezcat Biosciences
Patents, Royalties, Other Intellectual Property - Johns Hopkins University has licensed a patent related to pancreatic cancer to Thrive Earlier Detection. I have 1.8% contribution on that patent. No royalties have been received by me.; Royalties from Hangzhou Guangkeande (Cosmos) Biotechnology Company LTD for blood based biomarkers of early pancreatic cancer. I do not own stocks in the company nor do I have any research or grant funding from them.
 
Manuel Hidalgo
Leadership - BMS
Stock and Other Ownership Interests - Agenus; BioOncotech; Champions Oncology; InxMed; Nelum Corp.; Pharmacyte Biotech
Honoraria - InxMed; KHAR Medical; MinKi; Oncomatrix
Consulting or Advisory Role - Agenus; InxMed; KAHR Medical; Minki; Oncomatrix
Research Funding - BiolineRx; ERYTECH Pharma
Patents, Royalties, Other Intellectual Property - Royalties from Khar Medical for IP in cell therapy; Royalties from Myriad for PALB2 patent
Expert Testimony - Myriad Genetics
 
Andrew Eugene Hendifar
Consulting or Advisory Role - Abbvie; Celgene; Eisai; Ipsen; Novartis; Perthera; Valar Labs
Research Funding - Ipsen; NGM Biopharmaceuticals (Inst)
Travel, Accommodations, Expenses - Halozyme
Other Relationship - FibroGen
 
Gregory Lawrence Beatty
Stock and Other Ownership Interests - Johnson & Johnson
Honoraria - Incyte; Janssen
Consulting or Advisory Role - Adicet Bio; Aduro Biotech; AstraZeneca; BiolineRx; Boehringer Ingelheim; Bristol-Myers Squibb; Cantargia AB; Cour Pharmaceuticals; Genmab; Hibercell; Hotspot Therapeutics; Incyte; Janssen; Merck; Molecular Partners; Monopteros Therapeutics; NanoGhost; Pancreatic Cancer Action Network; Seagen; Shattuck Labs; Verastem
Research Funding - Alligator Bioscience; Arcus Biosciences; Biothera; Bristol-Myers Squibb; Genmab; Halozyme; Hibercell; Incyte; Janssen; Monopteros Therapeutics; Newlink Genetics; Novartis; Verastem
Patents, Royalties, Other Intellectual Property - Inventor of intellectual property related to mesothelin CAR T cells that is licensed by the University of Pennsylvania to Novartis.; Inventor of intellectual property related to mesothelin CAR T cells that is licensed by the University of Pennsylvania to Tmnuity.
 
Sudheer Doss
Stock and Other Ownership Interests - Exact Sciences
Research Funding - FibroGen (Inst); Novartis (Inst); Tyme Inc. (Inst)
Other Relationship - Abbvie (Inst); Allergan Foundation (Inst); Amgen (Inst); AngioDynamics (Inst); AstraZeneca (Inst); Baxter International Foundation (Inst); Boston Biomedical (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Elstar Therapeutics (Inst); ERYTECH Pharma (Inst); Genentech (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Halozyme (Inst); Immunovia (Inst); Interpace Diagnostics (Inst); Ipsen (Inst); Janssen Research & Development (Inst); Johnson & Johnson (Inst); Lilly (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Myriad Genetics (Inst); Novartis (Inst); Novartis (Inst); Novocure (Inst); Pfizer (Inst); Rafael Pharmaceuticals (Inst); SERVIER (Inst); Shire (Inst); Takeda (Inst); TriSalus Life Sciences (Inst); TYME (Inst)
 
Lynn McCormick Matrisian
Other Relationship - Abbvie (Inst); Amgen Foundation (Inst); AstraZeneca (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Corcept Therapeutics (Inst); Covance/LabCorp (Inst); Elevation Oncology (Inst); FibroGen (Inst); Fujifilm (Inst); Genentech (Inst); GlaxoSmithKline (Inst); GRAIL (Inst); Immunovia (Inst); Ipsen (Inst); Johnson & Johnson (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Novocure (Inst); Pfizer (Inst); Rafael Pharmaceuticals (Inst); SERVIER (Inst); Takeda (Inst); Tempus (Inst); TriSalus Life Sciences (Inst); TYME (Inst); ViewRay (Inst)
 
Pamela S Herena
Consulting or Advisory Role - Amgen
 
Julie Fleshman
Other Relationship - Abbvie (Inst); Amgen Foundation (Inst); AstraZeneca (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Clearity; Corcept Therapeutics (Inst); Covance/LabCorp (Inst); Elevation Oncology (Inst); FibroGen (Inst); Fujifilm (Inst); Genentech (Inst); GlaxoSmithKline Foundation (Inst); GRAIL (Inst); Immunovia (Inst); Ipsen (Inst); Johnson & Johnson (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Myriad Genetics (Inst); Novartis (Inst); Novocure (Inst); Pfizer (Inst); Rafael Pharmaceuticals (Inst); SERVIER (Inst); Takeda (Inst); Tempus (Inst); TriSalus Life Sciences (Inst); TYME (Inst); ViewRay (Inst)
 
Michelle A. Detry
Employment - Berry Consultants
Consulting or Advisory Role - Berry Consultants
 
Donald A. Berry
No Relationships to Disclose
 
Diane M. Simeone
Consulting or Advisory Role - Celgene
Research Funding - Abbvie
Patents, Royalties, Other Intellectual Property - small royalties for my patent on pancreatic cancer stem cells also I receive an annual royalty for a textbook I edited Greenfields Textbook of Surgery
Travel, Accommodations, Expenses - Konica Minolta Precision Medicine